

Novartis CEO, Activism in Match, Boeing Latest 01/09/24
Jan 9, 2024
Brent Saunders, Chairman and CEO of Bausch + Lomb, shares insights on the future of eye care innovation. He highlights the company's launch of a new drug for dry eye disease and the ongoing challenges related to supply chain issues. Saunders discusses the alarming rise of myopia in children linked to screen time and emphasizes the importance of outdoor activity. Additionally, he reflects on Bausch's strategic separation from Bausch Health and the promising growth in the iHealth market.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9
Intro
00:00 • 3min
Aerospace Market Dynamics and Challenges
03:26 • 12min
Employment Trends and Healthcare Insights
15:27 • 3min
Innovations and Challenges in Eye Health
18:51 • 5min
The Rising Epidemic of Myopia in Children
24:10 • 3min
Navigating Pharmaceutical Ambitions
27:40 • 7min
Transformative Success in R&D: A Pharmaceutical Company's Journey
34:12 • 2min
Navigating Challenges: CEO Perspectives for 2024
35:46 • 10min
Regulatory Challenges and Market Insights in Tech Investments
45:38 • 2min